Gene therapy developer 4D Molecular Therapeutics has appointed Fred Kamal to serve as chief technical officer. Kamal joins Emeryville, CA-based 4D Molecular from Avexis, where he was senior vice president of quality and regulatory CMC (chemistry, manufacturing, and controls). Last September, 4D Molecular raised $90 million as it prepared for a clinical trial testing its gene therapy for choroideremia, a condition characterized by progressive vision loss.
In other moves, 4D Molecular promoted Peter Francis to chief medical officer and Theresa Janke to chief operating officer. The company also named August Moretti its chief financial officer.
